The World's First
Personalized Therapy
Powered by automated platform for industrialization
A paradigm shift in lymphocyte mediated diseases: selective elimination of pathological clones while preserving physiological immunity
Selectivity Is Key
Selectivity: targeted elimination of diseased cells with no damage to healthy cells (i.e, no off-target toxicity)
.png)
TOXICITY
SELECTIVITY
The Paradigm Shift
From Standardized Medicine
To Personalized N-of-1 Therapies.
_edited_edited.png)
N-of-Many
_edited.png)
Traditional
Medicine
One drug fits all, regardless of molecular profile of patients
Examples:
Chemotherapy
N-of-Few
_edited.png)
Precision
Medicine
Subgroups stratified on the basis of shared molecular biomarkers.
Examples:
Trastuzumab (HER2+), CAR-T (CD19)
N-of-1
Personalized Medicine
Therapy designed and manufactured for a Single Patient. Gene therapy, SAMBA Personalized Antibodies
The Challenge
CURRENT APPROACHES (LIMITED) Isolated Academic Studies Manual Laboratory Pipelines with limited reproducibility and high variability
Our Solution
Healthcare systems, clinicians, and industry require a new manufacturing paradigm able to support patient-specific therapies with the same rigor, reproducibility, and traceability of traditional biologics. This requires automation, standardization, and digital control to transform personalized therapies from exceptional cases into a sustainable and scalable reality.
The Paradigm Shift
From Standardized Medicine
To Personalized N-of-1 Therapies.
THE MOST SELECTIVE THERAPY
AT THE COST OF THE CHEMOTHERAPY
Designed to operate within GMP-compliant manufacturing environments, ensuring regulatory alignment and clinical-grade quality.
Core innovations are protected by Granted Patents covering key aspects of therapeutic development.
Scientific Foundations Validated through
peer-reviewed publications and independent
academic research
A production model Designed to make Highly personalized biologics Economically and operationally sustainable.
Automation enables reproducibility,
traceability, and scalability across personalized therapeutic workflows.
Advanced computational tools
support molecular analysis and process optimization.
Eupaxx SpA Benefit Company
Industrial Engineering partner
Novalba Therapeutics Srl
AVATAR5 N-of-1 Design
Our Projects
From conventional antibody development to scalable, precision-driven immunotherapy platforms, powered by SAMBA.
N-of-Few
Avatar 1,2,3,4
N-of-1
Avatar 5
Our Team
Contact
GMP Certified
Patented Technology
Approved and Published by Official Scientific Community Publication Journal
Peer Reviewed
Sustainable
Ai Powered and Automated
TIBER BIOTECH
Via di Santa Croce in Gerusalemme 63,
00185 Rome, Italy